{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:44:43Z","timestamp":1792788283403,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","award":["CMRPG3M0811"],"award-info":[{"award-number":["CMRPG3M0811"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","award":["CMRPG381503"],"award-info":[{"award-number":["CMRPG381503"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","award":["CMRPG3C0763"],"award-info":[{"award-number":["CMRPG3C0763"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","award":["CMRPG3G0261"],"award-info":[{"award-number":["CMRPG3G0261"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","award":["CFRPG3L0011"],"award-info":[{"award-number":["CFRPG3L0011"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","award":["BMRPF99"],"award-info":[{"award-number":["BMRPF99"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Science and Technology","award":["106-2511-S-182A-002-MY2"],"award-info":[{"award-number":["106-2511-S-182A-002-MY2"]}]},{"name":"Ministry of Science and Technology","award":["108-2314-B-182A-050-MY3"],"award-info":[{"award-number":["108-2314-B-182A-050-MY3"]}]},{"name":"Ministry of Science and Technology","award":["111-2314-B-182A-133-MY3"],"award-info":[{"award-number":["111-2314-B-182A-133-MY3"]}]},{"name":"Ministry of Science and Technology","award":["NMRPG3M6231-3"],"award-info":[{"award-number":["NMRPG3M6231-3"]}]},{"name":"Ministry of Science and Technology","award":["NMRPG3G6411-2"],"award-info":[{"award-number":["NMRPG3G6411-2"]}]},{"name":"Ministry of Science and Technology","award":["NMRPG3J6131-3"],"award-info":[{"award-number":["NMRPG3J6131-3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To investigate the frequency of temporal lobe necrosis (TLN) soon after radiotherapy (RT) and identify differences among patients with various types of head and neck cancer (HNC) and between different RT methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively reviewed 483 patients with HNC who had completed RT in our hospital after January, 2015. These patients were followed-up at the radio-oncology department and received contrast-enhanced magnetic resonance imaging (MRI) or computed tomography (CT) to identify metastases or recurrence of cancer at regular intervals. Meanwhile, the occurrence of TLN, graded according to the Common Terminology Criteria for Adverse Events V5.0, was recorded. We categorized the patients into nasopharyngeal carcinoma (NPC) and non-NPC groups and compared the cumulative occurrence of TLN between the groups using Kaplan\u2013Meier and Cox regression analyses. We further compared the cumulative occurrence of TLN between proton beam therapy (PBT) and volumetric modulated arc therapy (VMAT) in patients with any HNC, NPC, and non-NPC HNC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared with the non-NPC group, the NPC group had a higher frequency of TLN (5.6% vs. 0.4%, \u2009\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u20090.01) and were more commonly associated with TLN in the Kaplan\u2013Meier analysis (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01) and the Cox regression model after covariates were adjusted for (adjusted hazard ratio: 13.35, 95% confidence interval: 1.37\u2013130.61) during the follow-up period. Furthermore, the frequency of TLN was similar between patients receiving PBT and those receiving VMAT (PBT vs. VMAT: 4.7% vs. 6.3%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.76). Kaplan\u2013Meier analysis revealed that the accumulated risks of TLN were similar between PBT and VMAT in patients with any HNC (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.44), NPC (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.84), and non-NPC HNC (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.70).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study demonstrated that patients with NPC are susceptible to TLN during the early period after RT. In addition, PBT may be associated with an equivalent risk of TLN when compared with VMAT in patients with NPC or other HNCs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13014-023-02344-y","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T06:01:53Z","timestamp":1695276113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Risk of temporal lobe necrosis between proton beam and volumetric modulated arc therapies in patients with different head and neck cancers"],"prefix":"10.1186","volume":"18","author":[{"given":"Chi-Hung","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Shen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chia","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Yu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hua","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pi-Shan","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Lin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Tung-Chieh","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang-Hsing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"key":"2344_CR1","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.oraloncology.2003.12.005","volume":"40","author":"OK Abayomi","year":"2004","unstructured":"Abayomi OK. Neck irradiation, carotid injury and its consequences. Oral Oncol. 2004;40:872\u20138.","journal-title":"Oral Oncol"},{"key":"2344_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.oraloncology.2018.02.021","volume":"80","author":"DJ Carpenter","year":"2018","unstructured":"Carpenter DJ, Mowery YM, Broadwater G, Rodrigues A, Wisdom AJ, Dorth JA, et al. The risk of carotid stenosis in head and neck cancer patients after radiation therapy. Oral Oncol. 2018;80:9\u201315.","journal-title":"Oral Oncol"},{"key":"2344_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.radonc.2013.08.009","volume":"110","author":"DM Gujral","year":"2014","unstructured":"Gujral DM, Chahal N, Senior R, Harrington KJ, Nutting CM. Radiation-induced carotid artery atherosclerosis. Radiother Oncol. 2014;110:31\u20138.","journal-title":"Radiother Oncol"},{"key":"2344_CR4","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.clon.2014.06.014","volume":"26","author":"LC Welsh","year":"2014","unstructured":"Welsh LC, Dunlop AW, McGovern T, McQuaid D, Dean JA, Gulliford SL, et al. Neurocognitive function after (chemo)-radiotherapy for head and neck cancer. Clin Oncol (R Coll Radiol). 2014;26:765\u201375.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2344_CR5","doi-asserted-by":"publisher","first-page":"14697","DOI":"10.1038\/s41598-017-13972-2","volume":"7","author":"SC Chen","year":"2017","unstructured":"Chen SC, Abe Y, Fang PT, Hsieh YJ, Yang YI, Lu TY, et al. Prognosis of hippocampal function after sub-lethal irradiation brain Injury in patients with nasopharyngeal carcinoma. Sci Rep. 2017;7:14697.","journal-title":"Sci Rep"},{"key":"2344_CR6","doi-asserted-by":"crossref","unstructured":"Zheng Z, Wang B, Zhao Q, Zhang Y, Wei J, Meng L et al. Research progress on mechanism and imaging of temporal lobe injury induced by radiotherapy for head and neck cancer. Eur Radiol 2021.","DOI":"10.1007\/s00330-021-08164-6"},{"key":"2344_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11864-018-0546-9","volume":"19","author":"JK Kim","year":"2018","unstructured":"Kim JK, Leeman JE, Riaz N, McBride S, Tsai CJ, Lee NY. Proton therapy for head and neck cancer. Curr Treat Options Oncol. 2018;19:28.","journal-title":"Curr Treat Options Oncol"},{"key":"2344_CR8","doi-asserted-by":"publisher","first-page":"e2113205","DOI":"10.1001\/jamanetworkopen.2021.13205","volume":"4","author":"X Li","year":"2021","unstructured":"Li X, Kitpanit S, Lee A, Mah D, Sine K, Sherman EJ, et al. Toxicity profiles and survival outcomes among patients with nonmetastatic nasopharyngeal carcinoma treated with intensity-modulated proton therapy vs intensity-modulated radiation therapy. JAMA Netw Open. 2021;4:e2113205.","journal-title":"JAMA Netw Open"},{"key":"2344_CR9","doi-asserted-by":"crossref","unstructured":"Chou YC, Fan KH, Lin CY, Hung TM, Huang BS, Chang KP et al. Intensity modulated proton beam therapy versus volumetric modulated arc therapy for patients with nasopharyngeal cancer: a propensity score-matched study. Cancers. 2021;13.","DOI":"10.3390\/cancers13143555"},{"key":"2344_CR10","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1016\/S1470-2045(17)30179-1","volume":"18","author":"JE Leeman","year":"2017","unstructured":"Leeman JE, Romesser PB, Zhou Y, McBride S, Riaz N, Sherman E, et al. Proton therapy for head and neck cancer: expanding the therapeutic window. Lancet Oncol. 2017;18:e254\u201365.","journal-title":"Lancet Oncol"},{"key":"2344_CR11","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.ijrobp.2021.02.018","volume":"110","author":"YY Zhang","year":"2021","unstructured":"Zhang YY, Huo WL, Goldberg SI, Slater JM, Adams JA, Deng XW, et al. Brain-specific relative biological effectiveness of protons based on long-term outcome of patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2021;110:984\u201392.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2344_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.clon.2023.01.024","volume":"35","author":"S Gaito","year":"2023","unstructured":"Gaito S, Hwang EJ, France A, Aznar MC, Burnet N, Crellin A, et al. Outcomes of patients treated in the UK proton overseas programme: Central Nervous System Group. Clin Oncol. 2023;35:283\u201391.","journal-title":"Clin Oncol"},{"key":"2344_CR13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.clon.2023.02.009","volume":"35","author":"E Hwang","year":"2023","unstructured":"Hwang E, Gaito S, France A, Crellin AM, Thwaites DI, Ahern V, et al. Outcomes of patients treated in the UK proton overseas programme: non-central nervous system group. Clin Oncol. 2023;35:292\u2013300.","journal-title":"Clin Oncol"},{"key":"2344_CR14","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S1470-2045(14)70268-2","volume":"15","author":"SH Patel","year":"2014","unstructured":"Patel SH, Wang Z, Wong WW, Murad MH, Buckey CR, Mohammed K, et al. Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis. Lancet Oncol. 2014;15:1027\u201338.","journal-title":"Lancet Oncol"},{"key":"2344_CR15","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.ijrobp.2022.01.047","volume":"113","author":"C Schroder","year":"2022","unstructured":"Schroder C, Kothe A, De Angelis C, Basler L, Fattori G, Safai S, et al. NTCP modeling for high-grade temporal radionecroses in a large cohort of patients receiving pencil beam scanning proton therapy for skull base and head and neck tumors. Int J Radiat Oncol Biol Phys. 2022;113:448\u201355.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2344_CR16","doi-asserted-by":"crossref","unstructured":"Lin YH, Cheng JY, Huang BS, Luo SD, Lin WC, Chou SY et al. Significant reduction in vertebral artery dose by intensity modulated proton therapy: a pilot study for nasopharyngeal carcinoma. J Pers Med. 2021;11.","DOI":"10.3390\/jpm11080822"},{"key":"2344_CR17","doi-asserted-by":"crossref","unstructured":"Wu PW, Huang CC, Lee YS, Chou YC, Fan KH, Lin CY et al. Post-irradiation sinus mucosa disease in nasopharyngeal carcinoma patients treated with intensity-modulated Proton Therapy. Cancers. 2022;14.","DOI":"10.3390\/cancers14010225"},{"key":"2344_CR18","doi-asserted-by":"publisher","first-page":"687","DOI":"10.21037\/jgo.2018.03.14","volume":"9","author":"M Chuong","year":"2018","unstructured":"Chuong M, Badiyan SN, Yam M, Li Z, Langen K, Regine W, et al. Pencil beam scanning versus passively scattered proton therapy for unresectable pancreatic cancer. J Gastrointest Oncol. 2018;9:687\u201393.","journal-title":"J Gastrointest Oncol"},{"key":"2344_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1748-717X-8-17","volume":"8","author":"SF Su","year":"2013","unstructured":"Su SF, Huang SM, Han F, Huang Y, Chen CY, Xiao WW, et al. Analysis of dosimetric factors associated with temporal lobe necrosis (TLN) in patients with nasopharyngeal carcinoma (NPC) after intensity modulated radiotherapy. Radiat Oncol. 2013;8:17.","journal-title":"Radiat Oncol"},{"key":"2344_CR20","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0360-3016(02)02754-2","volume":"53","author":"H Paganetti","year":"2002","unstructured":"Paganetti H, Niemierko A, Ancukiewicz M, Gerweck LE, Goitein M, Loeffler JS, et al. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys. 2002;53:407\u201321.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2344_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jfma.2016.03.005","volume":"116","author":"HM Wang","year":"2017","unstructured":"Wang HM, Lin CY, Hsieh CH, Hsu CL, Fan KH, Chang JT, et al. Induction chemotherapy with dose-modified docetaxel, cisplatin, and 5-fluorouracil in Asian patients with borderline resectable or unresectable head and neck cancer. J Formos Med Assoc. 2017;116:185\u201392.","journal-title":"J Formos Med Assoc"},{"key":"2344_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.oraloncology.2018.07.020","volume":"85","author":"L Lu","year":"2018","unstructured":"Lu L, Sheng Y, Zhang G, Li Y, OuYang PY, Ge Y, et al. Temporal lobe injury patterns following intensity modulated radiotherapy in a large cohort of nasopharyngeal carcinoma patients. Oral Oncol. 2018;85:8\u201314.","journal-title":"Oral Oncol"},{"key":"2344_CR23","unstructured":"Common Terminology Criteria for Adverse Events. (CTCAE v5.0). [https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_5x7.pdf."},{"key":"2344_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijrobp.2009.02.091","volume":"76","author":"YR Lawrence","year":"2010","unstructured":"Lawrence YR, Li XA, el Naqa I, Hahn CA, Marks LB, Merchant TE, et al. Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys. 2010;76:20\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2344_CR25","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ijrobp.2019.06.2540","volume":"105","author":"AW Lee","year":"2019","unstructured":"Lee AW, Ng WT, Pan JJ, Chiang CL, Poh SS, Choi HC, et al. International guideline on dose prioritization and acceptance criteria in radiation therapy planning for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2019;105:567\u201380.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2344_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.14338\/IJPT-20-00014.1","volume":"6","author":"S Kitpanit","year":"2020","unstructured":"Kitpanit S, Lee A, Pitter KL, Fan D, Chow JCH, Neal B, et al. Temporal lobe necrosis in head and neck cancer patients after proton therapy to the skull base. Int J Part Ther. 2020;6:17\u201328.","journal-title":"Int J Part Ther"},{"key":"2344_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13014-019-1229-9","volume":"14","author":"J Huang","year":"2019","unstructured":"Huang J, Kong FF, Oei RW, Zhai RP, Hu CS, Ying HM. Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study. Radiat Oncol. 2019;14:31.","journal-title":"Radiat Oncol"},{"key":"2344_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0901-5027(00)80016-8","volume":"29","author":"L Verhoef","year":"2000","unstructured":"Verhoef L, van der Kogel A. A patient who developed necrosis of the temporal lobe after irradiation of the parotid gland for pleomorphic adenoma. Int J Oral Maxillofac Surg. 2000;29:155.","journal-title":"Int J Oral Maxillofac Surg"},{"key":"2344_CR29","doi-asserted-by":"publisher","first-page":"593487","DOI":"10.3389\/fonc.2020.593487","volume":"10","author":"X Zhou","year":"2020","unstructured":"Zhou X, Liu P, Wang X. Temporal lobe necrosis following radiotherapy in nasopharyngeal carcinoma: new insight into the management. Front Oncol. 2020;10:593487.","journal-title":"Front Oncol"},{"key":"2344_CR30","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13014-020-01560-0","volume":"15","author":"VWC Wu","year":"2020","unstructured":"Wu VWC, Tam SY. Radiation induced temporal lobe necrosis in nasopharyngeal cancer patients after radical external beam radiotherapy. Radiat Oncol. 2020;15:112.","journal-title":"Radiat Oncol"},{"key":"2344_CR31","doi-asserted-by":"publisher","first-page":"e1392","DOI":"10.1212\/WNL.0000000000010190","volume":"95","author":"X Huang","year":"2020","unstructured":"Huang X, Zhang X, Wang X, Rong X, Li Y, Li H, et al. A nomogram to predict symptomatic epilepsy in patients with radiation-induced brain necrosis. Neurology. 2020;95:e1392\u2013403.","journal-title":"Neurology"},{"key":"2344_CR32","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1111\/epi.13924","volume":"58","author":"X Rong","year":"2017","unstructured":"Rong X, Yin J, Wang H, Zhang X, Peng Y. Statin treatment may lower the risk of postradiation epilepsy in patients with nasopharyngeal carcinoma. Epilepsia. 2017;58:2172\u20137.","journal-title":"Epilepsia"},{"key":"2344_CR33","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00401-015-1481-5","volume":"131","author":"A Vezzani","year":"2016","unstructured":"Vezzani A, Fujinami RS, White HS, Preux PM, Blumcke I, Sander JW, et al. Infections, inflammation and epilepsy. Acta Neuropathol. 2016;131:211\u201334.","journal-title":"Acta Neuropathol"},{"key":"2344_CR34","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.ijrobp.2015.11.037","volume":"94","author":"Q Shen","year":"2016","unstructured":"Shen Q, Lin F, Rong X, Yang W, Li Y, Cai Z, et al. Temporal cerebral microbleeds are associated with radiation necrosis and cognitive dysfunction in patients treated for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2016;94:1113\u201320.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2344_CR35","doi-asserted-by":"crossref","unstructured":"Voon NS, Abdul Manan H, Yahya N. Cognitive decline following radiotherapy of head and neck cancer: systematic review and meta-analysis of MRI correlates. Cancers. 2021;13.","DOI":"10.3390\/cancers13246191"},{"key":"2344_CR36","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1001\/archneur.57.9.1347","volume":"57","author":"M Cheung","year":"2000","unstructured":"Cheung M, Chan AS, Law SC, Chan JH, Tse VK. Cognitive function of patients with nasopharyngeal carcinoma with and without temporal lobe radionecrosis. Arch Neurol. 2000;57:1347\u201352.","journal-title":"Arch Neurol"},{"key":"2344_CR37","doi-asserted-by":"publisher","first-page":"100681","DOI":"10.1016\/j.adro.2021.100681","volume":"6","author":"S Nangia","year":"2021","unstructured":"Nangia S, Singh M, Khosa R, Rout SK, Singh G, Oomen S. The Hippocampus: a new organ at risk for postoperative radiation therapy for bucco-alveolar Cancer? A dosimetric and biological analysis. Adv Radiat Oncol. 2021;6:100681.","journal-title":"Adv Radiat Oncol"},{"key":"2344_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.clon.2021.09.010","volume":"34","author":"E Hwang","year":"2022","unstructured":"Hwang E, Burnet NG, Crellin AM, Ahern V, Thwaites DI, Gaito S, et al. A novel model and infrastructure for clinical outcomes data collection and their systematic evaluation for UK patients receiving proton beam therapy. Clin Oncol. 2022;34:11\u20138.","journal-title":"Clin Oncol"},{"key":"2344_CR39","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1148\/radiol.09090428","volume":"254","author":"YX Wang","year":"2010","unstructured":"Wang YX, King AD, Zhou H, Leung SF, Abrigo J, Chan YL, et al. Evolution of radiation-induced brain injury: MR imaging-based study. Radiology. 2010;254:210\u20138.","journal-title":"Radiology"},{"key":"2344_CR40","doi-asserted-by":"publisher","first-page":"4793517","DOI":"10.1155\/2021\/4793517","volume":"2021","author":"X Yang","year":"2021","unstructured":"Yang X, Ren H, Fu J. Treatment of radiation-induced brain necrosis. Oxid Med Cell Longev. 2021;2021:4793517.","journal-title":"Oxid Med Cell Longev"},{"key":"2344_CR41","doi-asserted-by":"publisher","first-page":"593449","DOI":"10.3389\/fonc.2021.593449","volume":"11","author":"G Liao","year":"2021","unstructured":"Liao G, Khan M, Zhao Z, Arooj S, Yan M, Li X. Bevacizumab treatment of radiation-induced brain necrosis: a systematic review. Front Oncol. 2021;11:593449.","journal-title":"Front Oncol"},{"key":"2344_CR42","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0022-510X(03)00007-8","volume":"209","author":"K Kohshi","year":"2003","unstructured":"Kohshi K, Imada H, Nomoto S, Yamaguchi R, Abe H, Yamamoto H. Successful treatment of radiation-induced brain necrosis by hyperbaric oxygen therapy. J Neurol Sci. 2003;209:115\u20137.","journal-title":"J Neurol Sci"},{"key":"2344_CR43","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1002\/1097-0142(19880415)61:8<1535::AID-CNCR2820610809>3.0.CO;2-E","volume":"61","author":"AW Lee","year":"1988","unstructured":"Lee AW, Ng SH, Ho JH, Tse VK, Poon YF, Tse CC, et al. Clinical diagnosis of late temporal lobe necrosis following radiation therapy for nasopharyngeal carcinoma. Cancer. 1988;61:1535\u201342.","journal-title":"Cancer"},{"key":"2344_CR44","doi-asserted-by":"publisher","first-page":"e528","DOI":"10.1016\/j.clon.2023.05.014","volume":"35","author":"S Gaito","year":"2023","unstructured":"Gaito S, Aznar MC, Burnet NG, Crellin A, France A, Indelicato D, et al. Assessing equity of access to proton beam therapy: a literature review. Clin Oncol. 2023;35:e528\u201336.","journal-title":"Clin Oncol"},{"key":"2344_CR45","doi-asserted-by":"publisher","first-page":"20211175","DOI":"10.1259\/bjr.20211175","volume":"95","author":"NG Burnet","year":"2022","unstructured":"Burnet NG, Mee T, Gaito S, Kirkby NF, Aitkenhead AH, Anandadas CN, et al. Estimating the percentage of patients who might benefit from proton beam therapy instead of X-ray radiotherapy. Br J Radiol. 2022;95:20211175.","journal-title":"Br J Radiol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-023-02344-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-023-02344-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-023-02344-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T11:10:25Z","timestamp":1700478625000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-023-02344-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2344"],"URL":"https:\/\/doi.org\/10.1186\/s13014-023-02344-y","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,21]]},"assertion":[{"value":"18 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Institutional Review Board of Chang Gung Memorial Hospital (202101981B0 and 202200464B0).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"155"}}